In a Large General Practice Dataset, Use of the CHA₂DS₂-VA Score Leads to Almost Universal Recommendation for Anticoagulation Treatment in Atrial Fibrillation Patients Aged 65 Years and Over
Heart Lung and Circulation(2022)
摘要
For high-risk atrial fibrillation (AF) patients, treatment with oral anticoagulants (OAC) can reduce stroke risk by two-thirds. From 2012–14, OAC treatment recommendations in international guidelines moved from CHADS₂≥2 to CHA₂DS₂-VASc≥2(men)/≥3(women), equivalent to CHA₂DS₂-VA≥2.
更多查看译文
关键词
atrial fibrillation patients,atrial fibrillation,anticoagulation treatment
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要